Paying user area
Try for free
Boston Scientific Corp. pages available for free this week:
- Common-Size Balance Sheet: Assets
- Analysis of Liquidity Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Capital Asset Pricing Model (CAPM)
- Operating Profit Margin since 2005
- Current Ratio since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Boston Scientific Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Total asset turnover | = | Net sales1 | ÷ | Total assets1 | |
---|---|---|---|---|---|
Dec 31, 2022 | = | ÷ | |||
Dec 31, 2021 | = | ÷ | |||
Dec 31, 2020 | = | ÷ | |||
Dec 31, 2019 | = | ÷ | |||
Dec 31, 2018 | = | ÷ | |||
Dec 31, 2017 | = | ÷ | |||
Dec 31, 2016 | = | ÷ | |||
Dec 31, 2015 | = | ÷ | |||
Dec 31, 2014 | = | ÷ | |||
Dec 31, 2013 | = | ÷ | |||
Dec 31, 2012 | = | ÷ | |||
Dec 31, 2011 | = | ÷ | |||
Dec 31, 2010 | = | ÷ | |||
Dec 31, 2009 | = | ÷ | |||
Dec 31, 2008 | = | ÷ | |||
Dec 31, 2007 | = | ÷ | |||
Dec 31, 2006 | = | ÷ | |||
Dec 31, 2005 | = | ÷ |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
- Net Sales
- Net sales exhibited a generally upward trajectory from 2005 to 2022. The figure increased from approximately $6.3 billion in 2005 to nearly $12.7 billion in 2022, indicating significant revenue growth over the period. There were occasional fluctuations, such as a slight decline in 2008 and 2010–2012, but the overall trend was positive, especially notable from 2013 onward where net sales consistently exceeded $7 billion and continued rising steadily.
- Total Assets
- Total assets showed substantial volatility early in the period, with a marked spike in 2006 to over $31 billion from about $8.2 billion in 2005, followed by a gradual decline to approximately $17 billion by 2012. Post-2012, total assets trended upward again, reaching around $32.5 billion by 2022. This pattern suggests possible strategic changes or asset revaluation occurring around the mid-2000s, with stabilization and growth in asset base in the later years.
- Total Asset Turnover Ratio
- The total asset turnover ratio remained relatively low in the mid-2000s, starting at 0.77 in 2005 but dropping sharply to around 0.25 in 2006 and remaining low until 2008. Following this dip, the ratio gradually improved through the early 2010s, peaking near 0.48 in 2017, indicating a higher efficiency in asset utilization to generate sales. However, after 2017, the ratio declined again to a range of 0.32 to 0.39 by 2022, reflecting a slight reduction in asset efficiency despite the increased asset base and net sales.
- Summary and Insights
- The company demonstrated strong revenue growth over the analyzed period, with net sales nearly doubling from 2005 to 2022. Total assets saw large fluctuations, particularly a dramatic increase and subsequent decrease in the mid-2000s, followed by steady growth afterward. The asset turnover ratio indicates mixed efficiency trends; the early sharp decline may reflect asset accumulation or restructuring, while mid-period improvements suggest better asset utilization. The recent decline in turnover ratio despite rising sales and assets could signal the need to monitor asset productivity closely in the future.
Comparison to Competitors
Boston Scientific Corp. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
---|---|---|---|---|---|---|---|
Dec 31, 2022 | |||||||
Dec 31, 2021 | |||||||
Dec 31, 2020 | |||||||
Dec 31, 2019 | |||||||
Dec 31, 2018 | |||||||
Dec 31, 2017 | |||||||
Dec 31, 2016 | |||||||
Dec 31, 2015 | |||||||
Dec 31, 2014 | |||||||
Dec 31, 2013 | |||||||
Dec 31, 2012 | |||||||
Dec 31, 2011 | |||||||
Dec 31, 2010 | |||||||
Dec 31, 2009 | |||||||
Dec 31, 2008 | |||||||
Dec 31, 2007 | |||||||
Dec 31, 2006 | |||||||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Boston Scientific Corp., total asset turnover, long-term trends, comparison to sector (health care equipment & services)
Boston Scientific Corp. | Health Care Equipment & Services | |
---|---|---|
Dec 31, 2022 | ||
Dec 31, 2021 | ||
Dec 31, 2020 | ||
Dec 31, 2019 | ||
Dec 31, 2018 | ||
Dec 31, 2017 | ||
Dec 31, 2016 | ||
Dec 31, 2015 | ||
Dec 31, 2014 | ||
Dec 31, 2013 | ||
Dec 31, 2012 | ||
Dec 31, 2011 | ||
Dec 31, 2010 | ||
Dec 31, 2009 | ||
Dec 31, 2008 | ||
Dec 31, 2007 | ||
Dec 31, 2006 | ||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Boston Scientific Corp., total asset turnover, long-term trends, comparison to industry (health care)
Boston Scientific Corp. | Health Care | |
---|---|---|
Dec 31, 2022 | ||
Dec 31, 2021 | ||
Dec 31, 2020 | ||
Dec 31, 2019 | ||
Dec 31, 2018 | ||
Dec 31, 2017 | ||
Dec 31, 2016 | ||
Dec 31, 2015 | ||
Dec 31, 2014 | ||
Dec 31, 2013 | ||
Dec 31, 2012 | ||
Dec 31, 2011 | ||
Dec 31, 2010 | ||
Dec 31, 2009 | ||
Dec 31, 2008 | ||
Dec 31, 2007 | ||
Dec 31, 2006 | ||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).